MarketPeel
Insider Trading Intelligence
CT

Carolyn E. Taylor

TNXP
DIRECTOR · TONIX PHARMACEUTICALS HOLDING CORP. · CIK 0001875324
FILING MIX · LIFETIME100%/0%
BUYS
8
SELLS
0
TOTAL VALUE
$30.0K
COMPANIES
1
ACTIVE SINCE
Jul 2021
HOLDINGS NOW
1,833
AVG SELL PX
TRADE KIND
SHOWING 8 / 8
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 2 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Carolyn E. Taylor, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+0.00%-14.06%+2.10%-16.16%-16.16%
14d1+0.00%-26.61%+2.13%-28.75%-28.75%
30d1+0.00%-27.48%+4.43%-31.91%-31.91%
60d1+0.00%-44.66%+5.63%-50.28%-50.28%
90d1+0.00%-53.36%+4.26%-57.62%-57.62%
180d1+0.00%-57.49%+7.44%-64.93%-64.93%
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TNXP · 1,833 shares · as of Jun 12, 2026
0532,8751,065,7501,598,6252,131,50020222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 8 buys / 0 sellsCOVERAGE · 20 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TNXP
TONIX PHARMACEUTICALS HOLDING CORP.
PURCHASE
1,415$10.55$14.9K1,833Jun 12, 2026Jun 15, 2026View →
TNXP
TONIX PHARMACEUTICALS HOLDING CORP.
PURCHASEGRANT
Stock grant
22,70022,700May 12, 2026May 14, 2026View →
TNXP
TONIX PHARMACEUTICALS HOLDING CORP.
PURCHASE
418$36.03$15.1K418Aug 21, 2025Aug 21, 2025View →
TNXP
TONIX PHARMACEUTICALS HOLDING CORP.
PURCHASEGRANT
Stock grant
10,00010,000May 13, 2025May 15, 2025View →
TNXP
TONIX PHARMACEUTICALS HOLDING CORP.
PURCHASEGRANT
Stock grant
104,621104,621May 23, 2024May 24, 2024View →
TNXP
TONIX PHARMACEUTICALS HOLDING CORP.
PURCHASEGRANT
Stock grant
60,00060,000May 8, 2023May 10, 2023View →
TNXP
TONIX PHARMACEUTICALS HOLDING CORP.
PURCHASEGRANT
Stock grant
2,131,5002,131,500May 9, 2022May 11, 2022View →
TNXP
TONIX PHARMACEUTICALS HOLDING CORP.
PURCHASEGRANT
Stock grant
237,437237,437Jul 16, 2021Jul 27, 2021View →
Other insiders · TNXP
Loading peer insiders…
About this filer
CIK 0001875324
ROLE
Director
PRIMARY
TNXP
COMPANIES
1
ACTIVE SINCE
Jul 2021
MARKETPEEL · /INSIDER/0001875324DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback